Pfirrmann, Daniel; Huber, Yvonne; Schattenberg, Joern Markus et al.
Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention StudyJOURNAL OF MEDICAL INTERNET RESEARCH. Bd. 21. H. 1. 2019
Simon, Perikles; Huber, Yvonne; Ptirrmann, Daniel et al.
Web-based Individualized Exercise Intervention Improves Physical Performance and Hepatic Inflammation in Patients with NAFLDMEDICINE AND SCIENCE IN SPORTS AND EXERCISE. Bd. 51. H. 6. 2019 S. 123-123
Wei, Teng; Weiler, Sofia Maria Elisabeth; Toth, Marcell et al.
YAP-dependent induction of UHMK1 supports nuclear enrichment of the oncogene MYBL2 and proliferation in liver cancer cellsONCOGENE. Bd. 38. H. 27. 2019 S. 5541-5550
Kahaly, George J.; Bartalena, Luigi; Hegedus, Lazlo et al.
2018 European Thyroid Association Guideline for the Management of Graves' HyperthyroidismEUROPEAN THYROID JOURNAL. Bd. 7. H. 4. 2018 S. 167-186
Doria, A.; Bass, D.; Schwarting, A. et al.
A 6-month open-label extension study of the safety and efficacy of subcutaneous belimumab in patients with systemic lupus erythematosusLUPUS. Bd. 27. H. 9. 2018 S. 1489-1498
Czauderna, C.; Koch, S.; Pilz, L. et al.
A high alpha-fetoprotein slope prior to therapy correlates with poor prognosis of patients with hepatocellular carcinomasJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S442-S442
Abou-Alfa, Ghassan K.; Chan, Stephen Lam; Furuse, Junji et al.
A randomized, multicenter phase 3 study of durvalumab (D) and tremelimumab (T) as first-line treatment in patients with unresectable hepatocellular carcinoma (HCC): HIMALAYA study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 15. 2018
Zhu, Andrew X.; Galle, Peter R.; Kudo, Masatoshi et al.
A study of ramucirumab (LY3009806) versus placebo in patients with hepatocellular carcinoma and elevated baseline alpha-fetoprotein (REACH-2).JOURNAL OF CLINICAL ONCOLOGY. Bd. 36. H. 4. 2018
Wangler, J.; Jansky, M.; Nguyen-Tat, M. et al.
Abklärung erhöhter Leberwerte - Wie erleben gastroenterologische Fachärzte die Zusammenarbeit mit Hausärzten?Zeitschrift für Allgemeinmedizin. Bd. 94. H. 12. 2018 S. 494 - 499
Sprinzl, M.; Grambihler, A.; Teuber, G. et al.
Addition of pegylated interferon alfa-2a to an ongoing nucleos(t) ide treatment accelerates decrease of HBs-antigen levels in patients with chronic hepatitis B: Results from the PADD-ON studyJOURNAL OF HEPATOLOGY. Bd. 68. 2018 S. S108-S109